{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:19:21Z","timestamp":1792815561336,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Relmada Therapeutics Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1038\/s41386-019-0501-x","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T01:02:58Z","timestamp":1566867778000},"page":"2230-2238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects"],"prefix":"10.1038","volume":"44","author":[{"given":"Manoela V.","family":"Foga\u00e7a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-3499","authenticated-orcid":false,"given":"Tina","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharine H.","family":"Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavio V.","family":"Vitolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"key":"501_CR1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617\u201327.","journal-title":"Arch Gen Psychiatry"},{"key":"501_CR2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1176\/ajp.156.7.1000","volume":"156","author":"TI Mueller","year":"1999","unstructured":"Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry. 1999;156:1000\u20136.","journal-title":"Am J Psychiatry"},{"key":"501_CR3","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905\u201317.","journal-title":"Am J Psychiatry"},{"key":"501_CR4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351\u20134.","journal-title":"Biol Psychiatry"},{"key":"501_CR5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate Jr.","year":"2006","unstructured":"Zarate CA Jr., Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63:856\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"501_CR6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","volume":"63","author":"S Maeng","year":"2008","unstructured":"Maeng S, Zarate CA Jr., Du J, Schloesser RJ, McCammon J, Chen G, et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry. 2008;63:349\u201352.","journal-title":"Biol Psychiatry"},{"key":"501_CR7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuropharm.2016.09.011","volume":"111","author":"AE Lepack","year":"2016","unstructured":"Lepack AE, Bang E, Lee B, Dwyer JM, Duman RS. Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures. Neuropharmacology. 2016;111:242\u201352.","journal-title":"Neuropharmacology"},{"key":"501_CR8","doi-asserted-by":"crossref","first-page":"pii: pyu033","DOI":"10.1093\/ijnp\/pyu033","volume":"18","author":"AE Lepack","year":"2014","unstructured":"Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS. BDNF release is required for the behavioral actions of ketamine. Int J Neuropsychopharmacol. 2014;18:pii: pyu033.","journal-title":"Int J Neuropsychopharmacol"},{"key":"501_CR9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22:238\u201349.","journal-title":"Nat Med"},{"key":"501_CR10","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010;329:959\u201364.","journal-title":"Science"},{"key":"501_CR11","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biopsych.2011.09.030","volume":"71","author":"RJ Liu","year":"2012","unstructured":"Liu RJ, Lee FS, Li XY, Bambico F, Duman RS, Aghajanian GK. Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex. Biol Psychiatry. 2012;71:996\u20131005.","journal-title":"Biol Psychiatry"},{"key":"501_CR12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature19766","volume":"538","author":"SC Harward","year":"2016","unstructured":"Harward SC, Hedrick NG, Hall CE, Parra-Bueno P, Milner TA, Pan E, et al. Autocrine BDNF-TrkB signalling within a single dendritic spine. Nature. 2016;538:99\u2013103.","journal-title":"Nature"},{"key":"501_CR13","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/npp.2013.128","volume":"38","author":"RJ Liu","year":"2013","unstructured":"Liu RJ, Fuchikami M, Dwyer JM, Lepack AE, Duman RS, Aghajanian GK. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology. 2013;38:2268\u201377.","journal-title":"Neuropsychopharmacology"},{"key":"501_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","volume":"5","author":"B Short","year":"2018","unstructured":"Short B, Fong J, Galvez V, Shelker W, Loo CK. Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry. 2018;5:65\u201378.","journal-title":"Lancet Psychiatry"},{"key":"501_CR15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/JCP.0000000000001035","volume":"39","author":"G Bernstein","year":"2019","unstructured":"Bernstein G, Davis K, Mills C, Wang L, McDonnell M, Oldenhof J, et al. Characterization of the safety and pharmacokinetic profile of D-methadone, a novel N-methyl-D-aspartate receptor antagonist in healthy, opioid-naive subjects: results of two phase 1 studies. J Clin Psychopharmacol. 2019;39:226\u201337.","journal-title":"J Clin Psychopharmacol"},{"key":"501_CR16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1213\/01.ANE.0000099723.75548.DF","volume":"98","author":"RJ Callahan","year":"2004","unstructured":"Callahan RJ, Au JD, Paul M, Liu C, Yost CS. Functional inhibition by methadone of N-methyl-D-aspartate receptors expressed in Xenopus oocytes: stereospecific and subunit effects. Anesth Analg. 2004;98:653\u20139.","journal-title":"Anesth Analg"},{"key":"501_CR17","doi-asserted-by":"crossref","first-page":"PL45","DOI":"10.1016\/0024-3205(94)00937-6","volume":"56","author":"K Kristensen","year":"1995","unstructured":"Kristensen K, Christensen CB, Christrup LL. Themu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci. 1995;56:PL45\u201350.","journal-title":"Life Sci"},{"key":"501_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(97)13391-2","volume":"223","author":"AL Gorman","year":"1997","unstructured":"Gorman AL, Elliott KJ, Inturrisi CE. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett. 1997;223:5\u20138.","journal-title":"Neurosci Lett"},{"key":"501_CR19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1476-5381.2010.00967.x","volume":"161","author":"A Matsui","year":"2010","unstructured":"Matsui A, Williams JT. Activation of micro-opioid receptors and block of Kir3 potassium channels and NMDA receptor conductance by L- and D-methadone in rat locus coeruleus. Br J Pharm. 2010;161:1403\u201313.","journal-title":"Br J Pharm"},{"key":"501_CR20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(00)01638-4","volume":"296","author":"BA Chizh","year":"2000","unstructured":"Chizh BA, Schlutz H, Scheede M, Englberger W. The N-methyl-D-aspartate antagonistic and opioid components of d-methadone antinociception in the rat spinal cord. Neurosci Lett. 2000;296:117\u201320.","journal-title":"Neurosci Lett"},{"key":"501_CR21","doi-asserted-by":"publisher","unstructured":"Hanania T, Manfredi PL, Inturrisi C,Vitolo OV. The N-methyl-D-aspartate receptor antagonist d-methadone acutely improves depressive-like behavior in the forced swim test performance of rats. Exp Clin Psychopharmacol, 2019. https:\/\/doi.org\/10.1037\/pha0000310 . [Epub ahead of print].","DOI":"10.1037\/pha0000310"},{"key":"501_CR22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.biopsych.2017.06.034","volume":"83","author":"TC Franklin","year":"2018","unstructured":"Franklin TC, Wohleb ES, Zhang Y, Fogaca M, Hare B, Duman RS. Persistent increase in microglial RAGE contributes to chronic stress-induced priming of depressive-like behavior. Biol Psychiatry. 2018;83:50\u201360.","journal-title":"Biol Psychiatry"},{"key":"501_CR23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.biopsych.2009.10.018","volume":"67","author":"O Malkesman","year":"2010","unstructured":"Malkesman O, Scattoni ML, Paredes D, Tragon T, Pearson B, Shaltiel G, et al. The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents. Biol Psychiatry. 2010;67:864\u201371.","journal-title":"Biol Psychiatry"},{"key":"501_CR24","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/npp.2016.202","volume":"42","author":"RJ Liu","year":"2017","unstructured":"Liu RJ, Duman C, Kato T, Hare B, Lopresto D, Bang E, et al. GLYX-13 produces rapid antidepressant responses with key synaptic and behavioral effects distinct from ketamine. Neuropsychopharmacology. 2017;42:1231\u201342.","journal-title":"Neuropsychopharmacology"},{"key":"501_CR25","doi-asserted-by":"crossref","first-page":"e1997","DOI":"10.1371\/journal.pone.0001997","volume":"3","author":"A Rodriguez","year":"2008","unstructured":"Rodriguez A, Ehlenberger DB, Dickstein DL, Hof PR, Wearne SL. Automated three-dimensional detection and shape classification of dendritic spines from fluorescence microscopy images. PLoS ONE. 2008;3:e1997.","journal-title":"PLoS One"},{"key":"501_CR26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","volume":"32","author":"LS Garcia","year":"2008","unstructured":"Garcia LS, Comim CM, Valvassori SS, Reus GZ, Barbosa LM, Andreazza AC, et al. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:140\u20134.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"501_CR27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","volume":"6","author":"P Willner","year":"2017","unstructured":"Willner P. The chronic mild stress (CMS) model of depression: History, evaluation and usage. Neurobiol Stress. 2017;6:78\u201393.","journal-title":"Neurobiol Stress"},{"key":"501_CR28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00187257","volume":"93","author":"P Willner","year":"1987","unstructured":"Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacol (Berl). 1987;93:358\u201364.","journal-title":"Psychopharmacol (Berl)"},{"key":"501_CR29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S1461145711001702","volume":"15","author":"JM Dwyer","year":"2012","unstructured":"Dwyer JM, Lepack AE, Duman RS. mTOR activation is required for the antidepressant effects of mGluR(2)\/(3) blockade. Int J Neuropsychopharmacol. 2012;15:429\u201334.","journal-title":"Int J Neuropsychopharmacol"},{"key":"501_CR30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature. 2011;475:91\u20135.","journal-title":"Nature"},{"key":"501_CR31","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/mp.2015.176","volume":"21","author":"FR Carreno","year":"2016","unstructured":"Carreno FR, Donegan JJ, Boley AM, Shah A, DeGuzman M, Frazer A, et al. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine. Mol Psychiatry. 2016;21:1298\u2013308.","journal-title":"Mol Psychiatry"},{"key":"501_CR32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuroscience.2012.08.010","volume":"223","author":"CY Liu","year":"2012","unstructured":"Liu CY, Jiang XX, Zhu YH, Wei DN. Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine produces antidepressant effects in rats: role of brain-derived neurotrophic factor. Neuroscience. 2012;223:219\u201324.","journal-title":"Neuroscience"},{"key":"501_CR33","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1038\/npp.2015.70","volume":"40","author":"RJ Liu","year":"2015","unstructured":"Liu RJ, Ota KT, Dutheil S, Duman RS, Aghajanian GK. Ketamine strengthens CRF-activated amygdala inputs to basal dendrites in mPFC layer V pyramidal cells in the prelimbic but not infralimbic subregion, a key suppressor of stress responses. Neuropsychopharmacology. 2015;40:2066\u201375.","journal-title":"Neuropsychopharmacology"},{"key":"501_CR34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","volume":"29","author":"W Zhou","year":"2014","unstructured":"Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Eur Psychiatry. 2014;29:419\u201323.","journal-title":"Eur Psychiatry"},{"key":"501_CR35","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/mp.2017.220","volume":"23","author":"T Kato","year":"2018","unstructured":"Kato T, Fogaca MV, Deyama S, Li XY, Fukumoto K, Duman RS. BDNF release and signaling are required for the antidepressant actions of GLYX-13. Mol Psychiatry. 2018;23:2007\u201317.","journal-title":"Mol Psychiatry"},{"key":"501_CR36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1073\/pnas.1814709116","volume":"116","author":"K Fukumoto","year":"2019","unstructured":"Fukumoto K, Fogaca MV, Liu RJ, Duman C, Kato T, Li XY, et al. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine. Proc Natl Acad Sci USA. 2019;116:297\u2013302.","journal-title":"Proc Natl Acad Sci USA"},{"key":"501_CR37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biopsych.2017.06.017","volume":"83","author":"S Ghosal","year":"2018","unstructured":"Ghosal S, Bang E, Yue W, Hare BD, Lepack AE, Girgenti MJ, et al. Activity-dependent brain-derived neurotrophic factor release is required for the rapid antidepressant actions of scopolamine. Biol Psychiatry. 2018;83:29\u201337.","journal-title":"Biol Psychiatry"},{"key":"501_CR38","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jpsychires.2013.03.008","volume":"47","author":"HK Muller","year":"2013","unstructured":"Muller HK, Wegener G, Liebenberg N, Zarate CA Jr., Popoli M, Elfving B. Ketamine regulates the presynaptic release machinery in the hippocampus. J Psychiatr Res. 2013;47:892\u20139.","journal-title":"J Psychiatr Res"},{"key":"501_CR39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbr.2016.09.002","volume":"316","author":"K Zhang","year":"2017","unstructured":"Zhang K, Yamaki VN, Wei Z, Zheng Y, Cai X. Differential regulation of GluA1 expression by ketamine and memantine. Behav Brain Res. 2017;316:152\u20139.","journal-title":"Behav Brain Res"},{"key":"501_CR40","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.biopsych.2008.06.027","volume":"64","author":"GM MacQueen","year":"2008","unstructured":"MacQueen GM, Yucel K, Taylor VH, Macdonald K, Joffe R. Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biol Psychiatry. 2008;64:880\u20133.","journal-title":"Biol Psychiatry"},{"key":"501_CR41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neubiorev.2009.01.004","volume":"33","author":"J Savitz","year":"2009","unstructured":"Savitz J, Drevets WC. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev. 2009;33:699\u2013771.","journal-title":"Neurosci Biobehav Rev"},{"key":"501_CR42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","volume":"135","author":"MV Foga\u00e7a","year":"2018","unstructured":"Foga\u00e7a MV, Campos AC, Coelho LD, Duman RS, Guimaraes FS. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling. Neuropharmacology. 2018;135:22\u201333.","journal-title":"Neuropharmacology"},{"key":"501_CR43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/neu.20025","volume":"60","author":"SC Cook","year":"2004","unstructured":"Cook SC, Wellman CL. Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J Neurobiol. 2004;60:236\u201348.","journal-title":"J Neurobiol"},{"key":"501_CR44","doi-asserted-by":"crossref","first-page":"pii: eaat8078","DOI":"10.1126\/science.aat8078","volume":"364","author":"RN Moda-Sava","year":"2019","unstructured":"Moda-Sava RN, Murdock MH, Parekh PK, Fetcho RN, Huang BS, Huynh TN, et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science. 2019;364:pii: eaat8078.","journal-title":"Science"},{"key":"501_CR45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00213-003-1718-1","volume":"173","author":"JS Wang","year":"2004","unstructured":"Wang JS, Ruan Y, Taylor RM, Donovan JL, Markowitz JS, DeVane CL. Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice. Psychopharmacol (Berl). 2004;173:132\u20138.","journal-title":"Psychopharmacol (Berl)"},{"key":"501_CR46","unstructured":"De Martin S VO, Bernstein G, Alimonti A, Traversa S, Inturrisi EC, Manfredi PL. The NMDAR antagonist dextromethadone increases plasma BDNF levels in healthy volunteers undergoing a 14-day in-patient phase 1 study. American College of Neuropsychopharmacology 2018 Annual Meeting, Miami, FL; 2018."}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0501-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0501-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0501-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:07:10Z","timestamp":1684602430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-019-0501-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":46,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["501"],"URL":"https:\/\/doi.org\/10.1038\/s41386-019-0501-x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736503643.793575804","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"21 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}